Roche (RHHBY) Stock Forecast & Price Target

$51.26 +0.08 (+0.16%)

As of 05/13/2026 03:59 PM Eastern

Compare

Roche - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 11 Analyst Ratings

Sell
0

Hold
6

Buy
5

Based on 11 Wall Street analysts who have issued ratings for Roche in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 6 have given a hold rating, and 5 have given a buy rating for RHHBY.

Consensus Price Target

$51.50
0.47% Upside

According to the 11 analysts' twelve-month price targets for Roche, the average price target is $51.50. The highest price target for RHHBY is $57.00, while the lowest price target for RHHBY is $46.00. The average price target represents a forecasted upside of 0.47% from the current price of $51.26.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for RHHBY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Roche and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RHHBY Analyst Ratings Over Time

Type	Current Forecast 5/14/25 to 5/14/26	1 Month Ago 4/14/25 to 4/14/26	3 Months Ago 2/13/25 to 2/13/26	1 Year Ago 5/14/24 to 5/14/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	2 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	3 Buy rating(s)	1 Buy rating(s)
Hold	6 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$51.50	$57.00	$57.00	N/A
Forecasted Upside	0.47% Upside	11.70% Upside	-2.58% Downside	N/A
Consensus Rating	Hold	Hold	Hold	Hold

RHHBY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

RHHBY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Roche Stock vs. The Competition

Type	Roche	Medical Companies	Broader Market
Consensus Rating Score	2.45	2.30	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	0.33% Upside	1,046.43% Upside	17.11% Upside
News Sentiment Rating	Positive News See Recent RHHBY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
4/24/2026	Morgan Stanley 3 of 5 stars		Upgrade	Underweight ➝ Equal Weight	$46.00	-11.30%
4/6/2026	Argus 3 of 5 stars		Upgrade	Hold ➝ Buy
2/26/2026	Wolfe Research 4 of 5 stars		Reiterated Rating	Outperform
2/10/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold
1/27/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Buy
1/15/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Sell ➝ Hold
1/6/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight
1/5/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
12/10/2025	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rajesh Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$57.00	+17.04%
12/8/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Underweight ➝ Neutral
Get the Latest News and Ratings for RHHBY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.
11/11/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Sell ➝ Hold
10/27/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold ➝ Moderate Sell
2/13/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Weston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
1/30/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	J. Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
9/13/2024	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Neutral ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 03:43 AM ET.

RHHBY Forecast - Frequently Asked Questions

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Roche is $51.50, with a high forecast of $57.00 and a low forecast of $46.00.

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Roche in the last year. There are currently 6 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" RHHBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RHHBY, but not buy additional shares or sell existing shares.

According to analysts, Roche's stock has a predicted upside of 0.47% based on their 12-month stock forecasts.

Over the previous 90 days, Roche's stock had 2 upgrades by analysts.

Roche has been rated by research analysts at Argus, Morgan Stanley, and Wolfe Research in the past 90 days.

Analysts like Roche more than other "medical" companies. The consensus rating score for Roche is 2.45 while the average consensus rating score for "medical" companies is 2.30. Learn more on how RHHBY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Roche Recommendations

This page (OTCMKTS:RHHBY) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Roche (RHHBY) Stock Forecast & Price Target

Roche - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

RHHBY Analyst Ratings Over Time

RHHBY Analyst Recommendations By Month

RHHBY Price Targets by Month

Roche Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

RHHBY Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Roche Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Roche (RHHBY) Stock Forecast & Price Target

Roche - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

RHHBY Analyst Ratings Over Time

RHHBY Analyst Recommendations By Month

RHHBY Price Targets by Month

Roche Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

RHHBY Forecast - Frequently Asked Questions

What is Roche's forecast for 2026?

Should I buy or sell Roche stock right now?

Does Roche's stock price have much upside?

Has Roche been upgraded by Wall Street analysts recently?

What analysts cover Roche?

Do Wall Street analysts like Roche more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Roche Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools